---
title: Improve Parkinson care via telemedicine
nct_id: NCT06479083
phase: NA
status: RECRUITING
sponsor: Johannes Gutenberg University Mainz
study_type: INTERVENTIONAL
canonical_url: "https://parkinsonspathways.com/trial/NCT06479083"
clinicaltrials_gov: "https://clinicaltrials.gov/study/NCT06479083"
last_fetched: "2026-05-10T14:08:09.116Z"
source: "Parkinson's Pathways (curated)"
---
# Improve Parkinson care via telemedicine

**Goal (in five words):** Improve Parkinson care via telemedicine

**Official Title:** Interdisciplinary and Intersectoral Telemedicine Evaluation, Coordination and Treatment in the Rhine Main+ Parkinson's Network

**Trial ID:** [NCT06479083](https://clinicaltrials.gov/study/NCT06479083)

## Key Facts

- **Phase:** NA
- **Status:** RECRUITING
- **Study Type:** INTERVENTIONAL
- **Sponsor:** Johannes Gutenberg University Mainz
- **Target Enrollment:** 1354 participants
- **Start Date:** 2024-07-01
- **Completion Date:** 2025-10-31
- **Conditions:** Parkinson Disease
- **Interventions:** New Intervention form including, Standard treatment
- **Intervention Types:** OTHER

## Summary For Families

The goal is to make specialist Parkinson's care easier to reach and better coordinated across the Rhine-Main region, so symptoms, medications and therapies can be reviewed and adjusted more quickly and consistently. The approach uses an interdisciplinary telemedicine package,video visits with neurologists, structured medication reviews, and coordinated referrals with shared electronic care plans,so teams can optimize levodopa and other treatments, manage side effects, and arrange local therapy without changing how the drugs work. Adults 30 to 85 years old living in Hesse or Rhineland-Palatinate with Parkinson's or atypical Parkinsonism who can give consent are eligible, while people with severe dementia, major psychiatric illness, active addiction, pregnancy, insufficient language skills, or participation in another interventional treatment trial are excluded.

## Eligibility

- **Minimum age:** 30 Years
- **Maximum age:** 85 Years
- **Sex:** ALL

### Full Criteria

```
Inclusion Criteria:

* Diagnosis of primary Parkinson's syndrome (G20.-) or atypical Parkinson's syndrome (G23.-, according to the current diagnostic criteria of the Movement Disorder Society, including the criteria of at least bradykinesia and rigidity or resting tremor must be present)
* In the care regions of Hesse and Rhineland-Palatinate
* Ability to give consent present

Exclusion Criteria:

\- Severe dementia

* Severe depression
* Psychoses or other psychiatric or medical comorbidities that could affect the smooth implementation of the study protocol (e.g.

tumor disease with limited life expectancy, need for dialysis, etc.)

* Drug or alcohol addiction
* Women who are pregnant or breastfeeding
* Simultaneous participation in another interventional treatment study
* Illiteracy or insufficient language skills
```

## Locations (2)

- Universtity of Saarland, Campus Homburg, Dept. of Neurology, Homburg, Germany _(49.3264, 7.3387)_
  - Sergiu Groppa — (CONTACT) — +49 68411624 — Sergiu.Groppa@uks.eu
- INSPIRE-PNRM+ Neuroimaging Center (NIC) University Medical Center of the Johannes Gutenberg University Mainz, Mainz, Germany _(49.9819, 8.2801)_
  - Franziska Beyer — (CONTACT) — +49 (0) 6131 17 — inspire-info@parkinsonnetzwerk.de
  - Selina Frühwald — (CONTACT) — +49 (0) 6131 17 — inspire-info@parkinsonnetzwerk.de
  - Sergiu Groppa — (PRINCIPAL_INVESTIGATOR)

## Central Contacts

- Sergiu Groppa, Prof. — (CONTACT) — +49 613117 — Sergiu.Groppa@uks.eu
- Franziska Beyer — (CONTACT) — +49 613117 — inspire-info@parkinsonnetzwerk.de

---

*Canonical: https://parkinsonspathways.com/trial/NCT06479083*  
*HTML version: https://parkinsonspathways.com/trial/NCT06479083*  
*Source data: https://clinicaltrials.gov/study/NCT06479083*